SCHEMBL8501307

SCHEMBL8501307

Cc1c(OCCSc2nc3ccccc3[nH]2)ccnc1CSc1nc2ccccc2[nH]1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.74
NPC1 O15118 2/20 0.74
CYP1A2 P05177 2/20 0.74
CYP2D6 P10635 2/20 0.74
CYP2C19 P33261 2/20 0.74
CYP3A4 P08684 1/20 0.74
RAB9A P51151 1/20 0.74
AR P10275 8/20 0.66
LMNA P02545 5/20 0.58
KMT2A Q03164 4/20 0.58
MAPT P10636 3/20 0.58
HTT P42858 2/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
TP53 P04637 1/20 0.58
MEN1 O00255 2/20 0.57
HPGD P15428 2/20 0.57
BCHE P06276 1/20 0.52
NOS3 P29474 1/20 0.51
NOS1 P29475 1/20 0.51
NOS2 P35228 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8502349 0.95 CYP2C9 (0.70) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL8503073 0.92 CYP2C9 (0.66) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL2992736 0.91 RAB9A (0.74) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL31515434 0.91 CYP2C9 (0.74) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL2986625 0.90 RAB9A (0.72) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL5352269 0.90 RAB9A (0.72) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL599742 0.90 CYP2C9 (0.72) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL9906214 0.90 RAB9A (0.76) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL8501941 0.90 CYP2C9 (0.72) CYP2C9NPC1CYP1A2CYP2D6CYP2C19
SCHEMBL15796996 0.90 RAB9A (0.72) CYP2C9NPC1CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998445-A PEPTIC ULCERS EISAI CO., LTD. (JP) 1999-12-07 US disclosed
EP-0786461-A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same Eisai Co., Ltd. (JP) 1997-07-30 EP disclosed
EP-0654471-A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and process for preparing the same Eisai Co., Ltd. (JP) 1995-05-24 EP disclosed
EP-0475456-A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same Eisai Co., Ltd. (JP) 1992-03-18 EP disclosed
US-5045552-A Pyridine derivatives having anti-ulcerative activity EISAI CO., LTD. (JP) 1991-09-03 US disclosed
EP-0268956-A2 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same Eisai Co., Ltd. (JP) 1988-06-01 EP disclosed